Tango Therapeutics Inc
TNGX
Market Cap$747.87M
Close$
$-7.36
243.8% downside
Current Fair Value
243.8% downsideOvervalued by 243.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $747.87 Million |
|---|---|
| Enterprise Value | $749.10 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-1.08 |
| Beta | 0.82 |
| Outstanding Shares | 108,314,279 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -6.49 |
|---|---|
| PEG | -125.41 |
| Price to Sales | - |
| Price to Book Ratio | 5.12 |
| Enterprise Value to Revenue | 18.27 |
| Enterprise Value to EBIT | -5.14 |
| Enterprise Value to Net Income | -6 |
| Total Debt to Enterprise | 0.08 |
| Debt to Equity | 0.36 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Tango Therapeutics Inc
4 employees